Billionaire Warren Buffett Is Buying Shares of a Mystery Stock: Here's Everything We Know

Key Points

Despite an endless sea of earnings reports and economic data releases, there are few events more anticipated by the investing community than the quarterly filing of Berkshire Hathaway 's (NYSE: BRK.A) (NYSE: BRK.B) Form 13F with the Securities and Exchange Commission (SEC).

A 13F provides investors with a snapshot of which stocks Wall Street's leading asset managers have been buying and selling, and it has to be filed no later than 45 calendar days following the end to a quarter. In other words, Berkshire's 13F lifts the hood for professional and everyday investors and allows them to see which stocks Buffett purchased and sold.

Billionaire Warren Buffett Is Buying Shares of a Mystery Stock: Here's Everything We Know

Thanks to Berkshire's May 15-filed 13F, along with various other regulatory filings, we know that Buffett was a buyer of 13 stocks during the March-ended quarter , as well as a seller of eight stocks. Even though the Oracle of Omaha has been a net-seller of equities for 10 consecutive quarters, there's something about knowing which stock(s) Buffett is buying that tugs on the heartstrings and pocketbooks of investors.

But what really stood out about Berkshire Hathaway's first-quarter 13F filing with the SEC was the attached confidential treatment clause.

Billionaire Warren Buffett is building a position in a secret stock

On rare occasion, select money managers (often prominent billionaire investors) can request confidential treatment from regulators to not report one or more existing positions on their quarterly filed 13F.

The reason a fund manager would request this is because investors would pile in and drive up the share price if the position were publicly revealed. If a high-profile money manager with a sizable Wall Street following can quietly build up their stake in a public company, they can likely do so at an advantageous price.

Over the last decade, Warren Buffett has leaned on this confidential treatment provision a couple of times. Most recently, Berkshire's billionaire chief began building up a large position in property and casualty insurer Chubb (NYSE: CB) under the secrecy of the confidential treatment tag.

OK